This 1-hour, webinar is part of 4 four-session webinar series that will translate clinical guidelines into actionable strategies for safer benzodiazepine tapering. This webinar includes expert-led discussions and case-based applications that will cover Considerations for Tapering Benzodiazepine in Primary Care.

This four-part webinar series features four one-hour webinars that explore key topics related to benzodiazepine tapering. This includes Considerations for Benzodiazepine Tapering, Benzodiazepine Tapering for Older Adults, Considerations for Tapering Benzodiazepine in Primary Care, and Addressing Benzodiazepine Tapering Challenges.

This 2-hour, on-demand session from the 2024 ASAM State of the Art Course focuses on the prevention and treatment of stimulant use disorders and will discuss topics such as new clinical practice guidelines, novel pharmacotherapies, methamphetamine-induced psychotic disorders, and more.

This 1-hour, on-demand session from the 2024 ASAM State of the Art Course outlines recent interesting findings and topics that have emerged, from differences in formulations and routes of administration to ways research may impact the future of policy.

This 16-hour live course includes 9 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 16-hour, on-demand course is the essential primer for physicians preparing for the addiction medicine examination and also serves to increase other healthcare professionals' knowledge of addiction.

This one-hour, on-demand, journal article-based activity presents a scoping review on the efficacy of GLP-1 agonists in the treatment of patients with substance use disorder. While there is interest in exploring the use of GLP-1 agonists in the treatment of SUD, evidence for safety and efficacy of GLP-1 agonists in humans is limited. The results of this scoping review are mixed, and the authors call for further research to determine the efficacy of GLP-1 agonists in treating SUD.

This one-hour, on-demand, journal article-based activity presents a scoping review on the prevalence of high-potency synthetic opioids (HPSOs) in the nonmedical drug supply and their interactions with medications for opioid use disorder (MOUDs). The interactions between HPSOs and MOUDs are not yet well understood. This review examines the relationship between HPSO exposure and patient outcomes when using common MOUD treatment protocols. It also discusses the implications for clinical practice and suggests directions for future research based on the current research on patient populations impacted by HPSOs.

This 6-hour online course series consists of 6 modules that cover the foundations of pain and addiction including the science, stigma, screening and assessment, treatment, and interdisciplinary approaches.

This 1-hour online module will discuss options for non-opioid and opioid pharmacological management of chronic pain, drug monitoring, limitations of the pharmacological approach, and treating acute pain. This is the fourth of six modules in The ASAM Pain & Addiction Essentials series.